Found: 69
Select item for more details and to access through your institution.
The way forward in HCV treatment — finding the right path.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
The way forward in HCV treatment — finding the right path.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
The way forward in HCV treatment — finding the right path.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 12, p. 991, doi. 10.1038/nrd2411
- By:
- Publication type:
- Article
Interferons at age 50: past, current and future impact on biomedicine.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy248
- By:
- Publication type:
- Article
Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 27, p. 1, doi. 10.2807/1560-7917.ES.2019.24.27.1800377
- By:
- Publication type:
- Article
Stat2 loss disrupts damage signalling and is protective in acute pancreatitis.
- Published in:
- Journal of Pathology, 2020, v. 252, n. 1, p. 41, doi. 10.1002/path.5481
- By:
- Publication type:
- Article
Triple combination treatment for chronic hepatitis C with Protease Inhibitors, pegylated interferon and ribavirin: 'Lead-in or no lead-in'?
- Published in:
- Liver International, 2012, p. 61, doi. 10.1111/j.1478-3231.2011.02717.x
- By:
- Publication type:
- Article
SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants.
- Published in:
- Journal of Medical Virology, 2017, v. 89, n. 9, p. 1620, doi. 10.1002/jmv.24809
- By:
- Publication type:
- Article
English hepatitis C registry data show high response rates to directly acting anti‐virals, even if treatment is not completed.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 1, p. 168, doi. 10.1111/apt.15780
- By:
- Publication type:
- Article
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25649-6
- By:
- Publication type:
- Article
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.
- Published in:
- European Journal of Public Health, 2012, v. 22, n. 2, p. 187, doi. 10.1093/eurpub/ckr083
- By:
- Publication type:
- Article
Therapy for chronic viral hepatitis: current indications, optimal therapies and delivery of care.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Therapy for chronic viral hepatitis: current indications, optimal therapies and delivery of care.
- Published in:
- Clinical Medicine, 2011, v. 11, n. 2, p. 184, doi. 10.7861/clinmedicine.11-2-184
- By:
- Publication type:
- Article
Diagnosis and treatment of chronic hepatitis B.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Diagnosis and treatment of chronic hepatitis B.
- Published in:
- Journal of the Royal Society of Medicine, 2004, v. 97, n. 7, p. 318, doi. 10.1177/014107680409700703
- By:
- Publication type:
- Article
Diagnosis and treatment of hepatitis C.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Diagnosis and treatment of hepatitis C.
- Published in:
- Journal of the Royal Society of Medicine, 2004, v. 97, n. 5, p. 223, doi. 10.1177/014107680409700504
- By:
- Publication type:
- Article
Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment.
- Published in:
- BMC Public Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12889-024-19919-3
- By:
- Publication type:
- Article
THE USE OF CT SCANNING IN DEMENTIAA Systematic Review.
- Published in:
- International Journal of Technology Assessment in Health Care, 1999, v. 15, n. 2, p. N.PAG, doi. 10.1017/s0266462399152115
- By:
- Publication type:
- Article
Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
- Published in:
- Scientific Reports, 2016, p. 25487, doi. 10.1038/srep25487
- By:
- Publication type:
- Article
Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Cryptosporidium parvum Infection Rapidly Induces a Protective Innate Immune Response Involving Type I Interferon.
- Published in:
- Journal of Infectious Diseases, 2009, v. 200, n. 10, p. 1548, doi. 10.1086/644601
- By:
- Publication type:
- Article
HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol.
- Published in:
- BMC Public Health, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12889-023-17290-3
- By:
- Publication type:
- Article
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1‐6 and compensated cirrhosis or advanced fibrosis.
- Published in:
- Liver International, 2018, v. 38, n. 3, p. 443, doi. 10.1111/liv.13534
- By:
- Publication type:
- Article
Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis.
- Published in:
- Liver International, 2016, v. 36, n. 1, p. 145, doi. 10.1111/liv.12891
- By:
- Publication type:
- Article
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study.
- Published in:
- Liver International, 2015, v. 35, n. 2, p. 448, doi. 10.1111/liv.12703
- By:
- Publication type:
- Article
Pegylated Interferons for the Treatment of Chronic Hepatitis C: Pharmacological and Clinical Differences between Peginterferon-α-2a and Peginterferon-α-2b.
- Published in:
- Drugs, 2010, v. 70, n. 2, p. 147, doi. 10.2165/11531990-000000000-00000
- By:
- Publication type:
- Article
Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230893
- By:
- Publication type:
- Article
Ethnicity and the diagnosis gap in liver disease: a population-based study.
- Published in:
- British Journal of General Practice, 2014, v. 64, n. 628, p. e694, doi. 10.3399/bjgp14X682273
- By:
- Publication type:
- Article
Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Informing the design of a national screening and treatment programme for chronic viral hepatitis in primary care: qualitative study of at-risk immigrant communities and healthcare professionals.
- Published in:
- BMC Health Services Research, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12913-015-0746-y
- By:
- Publication type:
- Article
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 11, p. 1479, doi. 10.1093/cid/ciw579
- By:
- Publication type:
- Article
Ribavirin-Free RegimenWith Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 8, p. 1042, doi. 10.1093/cid/ciw496
- By:
- Publication type:
- Article
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2016, v. 15, n. 3, p. 333, doi. 10.5604/16652681.1198803
- By:
- Publication type:
- Article
Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens.
- Published in:
- Immunology, 2005, v. 116, n. 2, p. 245, doi. 10.1111/j.1365-2567.2005.02218.x
- By:
- Publication type:
- Article
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 8, p. 1, doi. 10.1371/journal.ppat.1005788
- By:
- Publication type:
- Article
Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.
- Published in:
- Annals of Gastroenterology, 2017, v. 30, n. 3, p. 327, doi. 10.20524/aog.2017.0136
- By:
- Publication type:
- Article
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus‐infected people who inject drugs in England.
- Published in:
- Addiction, 2019, v. 114, n. 6, p. 1113, doi. 10.1111/add.14569
- By:
- Publication type:
- Article
Injecting drug users with chronic hepatitis C: should they be offered antiviral therapy?
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0168713
- By:
- Publication type:
- Article
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1).
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158526
- By:
- Publication type:
- Article
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0151703
- By:
- Publication type:
- Article
Influencing Factors on the Outcome and Prognosis of Patients With HBV Infection: Seven Years Follow-up.
- Published in:
- Hepatitis Monthly, 2013, v. 13, n. 7, p. 1, doi. 10.5812/hepatmon.8743
- By:
- Publication type:
- Article
Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2018, v. 98, n. 4, p. 1152, doi. 10.4269/ajtmh.17-0637
- By:
- Publication type:
- Article
Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection.
- Published in:
- 2019
- By:
- Publication type:
- journal article